Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hypoxia-inducible factor 1 in autoimmune diseases.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
[Epidemiology of multiple sclerosis].
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Neurourologic dysfunction: evaluation, surveillance and therapy.
Viral vectors for therapy of neurologic diseases.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Therapy of NMO spectrum disorders.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Fatigue and heat sensitivity in patients with multiple sclerosis.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
716
717
718
719
720
721
722
723
724
…
next ›
last »